WO2022101161A3 - Point-of-care test for a group of individuals - Google Patents

Point-of-care test for a group of individuals Download PDF

Info

Publication number
WO2022101161A3
WO2022101161A3 PCT/EP2021/081026 EP2021081026W WO2022101161A3 WO 2022101161 A3 WO2022101161 A3 WO 2022101161A3 EP 2021081026 W EP2021081026 W EP 2021081026W WO 2022101161 A3 WO2022101161 A3 WO 2022101161A3
Authority
WO
WIPO (PCT)
Prior art keywords
point
individuals
group
care test
care
Prior art date
Application number
PCT/EP2021/081026
Other languages
French (fr)
Other versions
WO2022101161A2 (en
Inventor
Christofer Toumazou
Original Assignee
Dnanudge Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2017742.4A external-priority patent/GB2600774A/en
Priority claimed from US17/094,190 external-priority patent/US11384403B2/en
Application filed by Dnanudge Limited filed Critical Dnanudge Limited
Priority to CN202180089635.1A priority Critical patent/CN116724123A/en
Publication of WO2022101161A2 publication Critical patent/WO2022101161A2/en
Publication of WO2022101161A3 publication Critical patent/WO2022101161A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

The present invention relates to the use of pooled samples to optimise the efficiency and utility of a rapid, lab-free point-of-care test. It is applicable in particular, though not necessarily, to tests for SARS-CoV-2.
PCT/EP2021/081026 2020-11-10 2021-11-09 Point-of-care test for a group of individuals WO2022101161A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202180089635.1A CN116724123A (en) 2020-11-10 2021-11-09 Instant detection for a group of individuals

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US17/094,190 2020-11-10
GB2017742.4 2020-11-10
GB2017742.4A GB2600774A (en) 2020-11-10 2020-11-10 The use of pooled samples to optimise the efficiency and utility of a rapid, lab-free point-of-care test
US17/094,190 US11384403B2 (en) 2020-11-10 2020-11-10 Use of pooled samples to optimise the efficiency and utility of a rapid, lab-free point-of-care test
GB2019173.0 2020-12-04
GB2019173.0A GB2600778B (en) 2020-11-10 2020-12-04 Point-of-care test for a group of individuals

Publications (2)

Publication Number Publication Date
WO2022101161A2 WO2022101161A2 (en) 2022-05-19
WO2022101161A3 true WO2022101161A3 (en) 2022-06-23

Family

ID=81602134

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2021/081026 WO2022101161A2 (en) 2020-11-10 2021-11-09 Point-of-care test for a group of individuals

Country Status (1)

Country Link
WO (1) WO2022101161A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10820847B1 (en) * 2019-08-15 2020-11-03 Talis Biomedical Corporation Diagnostic system
US20200347465A1 (en) * 2020-03-24 2020-11-05 DRK-Blutspendedienst Baden-Württemberg - Hessen gemeinnützige GmbH Detection of sars-cov-2 in a plurality of biological samples

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10544051B2 (en) 2016-06-27 2020-01-28 Joe Lynn Vickers Desalination unit with electricity generation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10820847B1 (en) * 2019-08-15 2020-11-03 Talis Biomedical Corporation Diagnostic system
US20200347465A1 (en) * 2020-03-24 2020-11-05 DRK-Blutspendedienst Baden-Württemberg - Hessen gemeinnützige GmbH Detection of sars-cov-2 in a plurality of biological samples

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ALISON BURDETT ET AL: "Pooled sputum to optimise the efficiency and utility of rapid, point-of-care molecular SARS-CoV-2 testing", BMC INFECTIOUS DISEASES, BIOMED CENTRAL LTD, LONDON, UK, vol. 21, no. 1, 8 July 2021 (2021-07-08), pages 1 - 10, XP021293654, DOI: 10.1186/S12879-021-06316-Z *
KHAI LONE LIM ET AL: "A novel strategy for community screening of SARS-CoV-2 (COVID-19): Sample pooling method", 28 August 2020 (2020-08-28), XP055800886, Retrieved from the Internet <URL:https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0238417/1/pone.0238417.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa@plos-prod.iam.gserviceaccount.com/20210503/auto/storage/goog4_request&X-Goog-Date=20210503T132542Z&X-Goog-Expires=3600&X-Goog-SignedHeaders=ho> [retrieved on 20210503] *
NUDGEBOX DNACARTRIDGE (TM): "Instructions For Use CovidNudge Test V4.1", 1 October 2020 (2020-10-01), XP055868709, Retrieved from the Internet <URL:https://www.ruh.nhs.uk/pathology/documents/poct/SOP_CovidNudge_Test_Instructions.pdf?t=81116.54> [retrieved on 20211202] *
SHENTAL NOAM ET AL: "Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers", SCIENCE ADVANCES, vol. 6, no. 37, 11 September 2020 (2020-09-11), XP055864265, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485993/pdf/abc5961.pdf> DOI: 10.1126/sciadv.abc5961 *
SUPAPORN WACHARAPLUESADEE ET AL: "Evaluating the efficiency of specimen pooling for PCR based detection of COVID 19", JOURNAL OF MEDICAL VIROLOGY, vol. 92, no. 10, 13 May 2020 (2020-05-13), US, pages 2193 - 2199, XP055763212, ISSN: 0146-6615, DOI: 10.1002/jmv.26005 *

Also Published As

Publication number Publication date
WO2022101161A2 (en) 2022-05-19

Similar Documents

Publication Publication Date Title
Nguyen et al. Yield stress measurements in suspensions: an inter-laboratory study
EP4249605A3 (en) Methods for analyte detection
TW200625078A (en) Method for optimizing test order, and machine-readable media storing sequences of instructions to perform same
WO2022101161A3 (en) Point-of-care test for a group of individuals
JP2019532261A5 (en)
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
WO2006133385A3 (en) Compositions, methods and kits for determining the presence of chlamydophila pneumoniae in a test sample
CN203534991U (en) Sheet test piece fixture used for scanning electron microscope (SEM)
GB202017742D0 (en) The use of pooled samples to optimise the efficiency and utility of a rapid, lab-free point-of-care test
WO2020224666A3 (en) Regenerative capability evaluation method for industrial lubricant regenerative adsorbent
CN207606319U (en) A kind of fixture applied on metal detecting apparatus
WO2021252733A3 (en) Sequence conversion reaction
EP4001434A3 (en) Salivary biomarker for diagnosing xerostomia and use thereof
WO2020264241A3 (en) Devices and methods for the detection of bacteria
CN205466471U (en) A chuck for constituting sealing member processing frock fixture
Shcherbyna et al. Silence as an argument and a manifestation of respect in the argumentation in John Locke's works
Dalia et al. THE IMPACT OF HUMAN RESOURCES ON ACHIEVING COMPETITIVE ADVANTAGE FOR THE ORGANIZATION
CN106644701B (en) A kind of acquisition methods of monocrystalline standard round bar test specimen specific orientation radial direction air film hole
WO2023211840A3 (en) Articles and methods for analyte concentration measurements
CN1477396A (en) Method for analyzing component temperature state by using carbide phase component change
Cantrell The introduction and development of the homeflow measurement instrument
CN204923879U (en) Furnace wall mounting tool of industrial furnace
Topper et al. Two out of three ain't bad: Dealing with proxy paucity when correlating the base of the Cambrian
Park et al. A Trend of Feminine Leadership Research (1998-2018)
Xiong et al. Notes on the genus Hyphodontia (Basidiomycota, Aphyllophorales) in China

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21809995

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 202180089635.1

Country of ref document: CN

122 Ep: pct application non-entry in european phase

Ref document number: 21809995

Country of ref document: EP

Kind code of ref document: A2